{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:54:07Z","timestamp":1777139647685,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10787-019-00586-5","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T11:02:51Z","timestamp":1553943771000},"page":"1071-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sumatriptan protects against myocardial ischaemia\u2013reperfusion injury by inhibition of inflammation in rat model"],"prefix":"10.1007","volume":"27","author":[{"given":"Mohammad","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedyeh","family":"Faghir-Ghanesefat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedieh","family":"Keshavarz-Bahaghighat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Sepand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-5565","authenticated-orcid":false,"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"586_CR1","unstructured":"Ambrose JA, Singh M (2015) Pathophysiology of coronary artery disease leading to acute coronary syndromes. F1000Prime Rep 7:08"},{"issue":"8","key":"586_CR2","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/j.pain.0000000000000581","volume":"157","author":"D Araldi","year":"2016","unstructured":"Araldi D, Ferrari LF, Levine JD (2016) Gi-protein coupled 5-HT1B\/D receptor agonist sumatriptan induces type I hyperalgesic priming. Pain 157(8):1773","journal-title":"Pain"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.peptides.2013.05.006","volume":"46","author":"Y Azizi","year":"2013","unstructured":"Azizi Y, Faghihi M, Imani A et al (2013) Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction. Peptides 46:76\u201382","journal-title":"Peptides"},{"key":"586_CR4","first-page":"1","volume":"34","author":"NM Barnes","year":"2011","unstructured":"Barnes NM, Neumaier JF (2011) Neuronal 5-HT receptors and SERT. Tocris Biosci Sci Rev Ser 34:1\u201316","journal-title":"Tocris Biosci Sci Rev Ser"},{"issue":"5","key":"586_CR5","first-page":"5042","volume":"7","author":"M Brahadeesh","year":"2016","unstructured":"Brahadeesh M, Suresha RN (2016) Screening of the drug amiodarone for its antiinflammatory potential in albino rats. IJPLS:7(5):5042\u20135046","journal-title":"IJPLS"},{"issue":"4","key":"586_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.carpath.2005.03.006","volume":"14","author":"LM Buja","year":"2005","unstructured":"Buja LM (2005) Myocardial ischaemia and re perfusion injury. Cardiovasc Pathol 14(4):170\u2013175","journal-title":"Cardiovasc Pathol"},{"issue":"8","key":"586_CR7","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/brain\/awq159","volume":"133","author":"M Felice De","year":"2010","unstructured":"De Felice M, Ossipov MH, Wang R et al (2010) Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 133(8):2475\u20132488","journal-title":"Brain"},{"issue":"5","key":"586_CR8","first-page":"587","volume":"15","author":"NS Dhalla","year":"1999","unstructured":"Dhalla NS, Golfman L, Takeda S et al (1999) Evidence for the role of oxidative stress in acute ischaemic heart disease: a brief review. Can J Cardiol 15(5):587\u2013593","journal-title":"Can J Cardiol"},{"issue":"3","key":"586_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1875042701103010065","volume":"3","author":"B Dobutovi\u0107","year":"2011","unstructured":"Dobutovi\u0107 B, Smiljani\u0107 K, Soski\u0107 S et al (2011) Nitric oxide and its role in cardiovascular diseases. Open Nitric Oxide J 3(3):65\u201371","journal-title":"Open Nitric Oxide J"},{"issue":"6","key":"586_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00424-010-0808-2","volume":"459","author":"U F\u00f6rstermann","year":"2010","unstructured":"F\u00f6rstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459(6):923\u2013939","journal-title":"Pflugers Arch"},{"issue":"1","key":"586_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"NG Frangogiannis","year":"2002","unstructured":"Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovascular res 53(1):31\u201347","journal-title":"Cardiovascular res"},{"key":"586_CR12","first-page":"C24","volume":"19","author":"M Gr\u00f8nholdt","year":"1998","unstructured":"Gr\u00f8nholdt M, Dalager-Pedersen S, Falk E (1998) Coronary atherosclerosis: determinants of plaque rupture. Eur Heart J 19:C24\u2013C29","journal-title":"Eur Heart J"},{"issue":"2","key":"586_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00403-018-1809-9","volume":"310","author":"NS Haddadi","year":"2018","unstructured":"Haddadi NS, Foroutan A, Shakiba S et al (2018) Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids. Arch Dermatol Res 310(2):165\u2013172","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"586_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1468-2982.1994.1406401.x","volume":"14","author":"P Humphrey","year":"1994","unstructured":"Humphrey P, Goadsby P (1994) The mode of action of sumatriptan is vascular? A debate. Cephalalgia 14(6):401\u2013410","journal-title":"A debate. Cephalalgia"},{"issue":"14","key":"586_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez B, Heusch G, Ovize M et al (2015) Evolving therapies for myocardial ischaemia\/re perfusion injury. J Am Coll Cardiol 65(14):1454\u20131471","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"586_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1046\/j.1526-4610.2002.02208.x","volume":"42","author":"Y Ikeda","year":"2002","unstructured":"Ikeda Y, Jimbo H, Shimazu M et al (2002) Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study. Headache 42(9):888\u2013892","journal-title":"Headache"},{"issue":"6","key":"586_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","volume":"109","author":"J-i Oyama","year":"2004","unstructured":"Oyama J-i, Blais C, Liu X et al (2004) Reduced myocardial ischaemia\u2013re perfusion injury in toll-like receptor 4-deficient mice. Circulation 109(6):784\u2013789","journal-title":"Circulation"},{"issue":"1","key":"586_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0167-5273(02)00189-4","volume":"86","author":"KA Kaminski","year":"2002","unstructured":"Kaminski KA, Bonda TA, Korecki J et al (2002) Oxidative stress and neutrophil activation\u2014the two keystones of ischaemia \/re perfusion injury. Int J Cardiol 86(1):41\u201359","journal-title":"Int J Cardiol"},{"key":"586_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuro.2018.06.012","volume":"67","author":"M Khalilzadeh","year":"2018","unstructured":"Khalilzadeh M, Panahi G, Rashidian A et al (2018) The protective effects of sumatriptan on vincristine-induced peripheral neuropathy in a rat model. Neurotoxicology 67:279\u2013286","journal-title":"Neurotoxicology"},{"issue":"3","key":"586_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","volume":"31","author":"L Mohammad-Zadeh","year":"2008","unstructured":"Mohammad-Zadeh L, Moses L, Gwaltney-Brant S (2008) Serotonin: a review. J Vet Pharmacol Ther 31(3):187\u2013199","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"586_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/physrev.00024.2007","volume":"88","author":"E Murphy","year":"2008","unstructured":"Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischaemia -re perfusion injury. Physiol Rev 88(2):581\u2013609","journal-title":"Physiol Rev"},{"issue":"5","key":"586_CR22","first-page":"587","volume":"15","author":"A Nazari","year":"1999","unstructured":"Nazari A, Sadr SS, Faghihi M, Azizi Y et al (1999) Evidence for the role of oxidative stress in acute ischaemic heart disease: a brief review. Can J Cardiol 15(5):587\u2013593","journal-title":"Can J Cardiol"},{"issue":"3","key":"586_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.pain.2008.06.002","volume":"139","author":"T Nikai","year":"2008","unstructured":"Nikai T, Basbaum AI, Ahn AH (2008) Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 139(3):533\u2013540","journal-title":"Pain"},{"issue":"3","key":"586_CR24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15420\/icr.2014.9.3.190","volume":"9","author":"J Rawlins","year":"2014","unstructured":"Rawlins J, Wilkinson J, Curzen N (2014) Evidence for benefit of percutaneous coronary intervention for chronically occluded coronary arteries (CTO)\u2013clinical and health economic outcomes. Interv Cardiol 9(3):190","journal-title":"Interv Cardiol"},{"issue":"5","key":"586_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0361-9230(01)00628-1","volume":"56","author":"C Roberts","year":"2001","unstructured":"Roberts C, Price GW, Middlemiss DN (2001) Ligands for the investigation of 5-HT autoreceptor function. Brain Res Bull 56(5):463\u2013469","journal-title":"Brain Res Bull"},{"issue":"1","key":"586_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainresbull.2006.04.004","volume":"70","author":"S Rutz","year":"2006","unstructured":"Rutz S, Riegert C, Rothmaier AK et al (2006) Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice. Brain Res Bull 70(1):81\u201393","journal-title":"Brain Res Bull"},{"issue":"3","key":"586_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cardiores.2003.09.019","volume":"61","author":"R Schulz","year":"2004","unstructured":"Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischaemia \/re perfusion injury. Send to Cardiovasc Res 61(3):402\u2013413","journal-title":"Send to Cardiovasc Res"},{"issue":"2","key":"586_CR28","first-page":"668","volume":"260","author":"MR Siegfried","year":"1992","unstructured":"Siegfried MR, Erhardt J, Rider T et al (1992) Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischaemia-re perfusion. J Pharmacol Exp Ther 260(2):668\u2013675","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"586_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0166-4328(96)00089-7","volume":"73","author":"M Skingle","year":"1995","unstructured":"Skingle M, Beattie DT, Scopes DI et al (1995) GR127935: a potent and selective 5-HT1D receptor antagonist. Behav Brain Res 73(1\u20132):157\u2013161","journal-title":"Behav Brain Res"},{"issue":"3","key":"586_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","volume":"106","author":"AT Turer","year":"2010","unstructured":"Turer AT, Hill JA (2010) Pathogenesis of myocardial ischaemia-re perfusion injury and rationale for therapy. Am J Cardiol 106(3):360\u2013368","journal-title":"Am J Cardiol"},{"issue":"2","key":"586_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0167-5273(87)90008-8","volume":"14","author":"PM Vanhoutte","year":"1987","unstructured":"Vanhoutte PM (1987) Serotonin and the vascular wall. Int J Cardiol 14(2):189\u2013203","journal-title":"Int J Cardiol"},{"issue":"4","key":"586_CR32","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1053\/j.gastro.2008.06.085","volume":"135","author":"LP Vera-Portocarrero","year":"2008","unstructured":"Vera-Portocarrero LP, Ossipov MH, King T et al (2008) Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. Gastroenterology 135(4):1369\u20131378","journal-title":"Gastroenterology"},{"issue":"9","key":"586_CR33","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/j.1582-4934.2012.01523.x","volume":"16","author":"J Wang","year":"2012","unstructured":"Wang J, Huang W, Xu R et al (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16(9):2150\u20132160","journal-title":"J Cell Mol Med"},{"issue":"1\u20132","key":"586_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-009-0098-1","volume":"330","author":"J Yang","year":"2009","unstructured":"Yang J, Jiang H, Yang J et al (2009) Valsartan preconditioning protects against myocardial ischaemia-re perfusion injury through TLR4\/NF-\u03baB signalling pathway. Mol Cell Biochem 330(1\u20132):39","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"586_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"C-H Yeh","year":"2002","unstructured":"Yeh C-H, Chen T-P, Wu Y-C et al (2002) The inflammatory response in myocardial infarction. Cardiovascular Res 53(1):31\u201347","journal-title":"Cardiovascular Res"},{"issue":"1\u20133","key":"586_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejphar.2012.11.005","volume":"699","author":"Y Yin","year":"2013","unstructured":"Yin Y, Guan Y, Duan J et al (2013) Cardioprotective effect of Danshensu against myocardial ischaemia\/re perfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1\/2 phosphorylation. Eur J Pharmacol 699(1\u20133):219\u2013226","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"586_CR37","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","volume":"285","author":"Z-Q Zhao","year":"2003","unstructured":"Zhao Z-Q, Corvera JS, Halkos ME et al (2003) Inhibition of myocardial injury by ischaemic postconditioning during re perfusion: comparison with ischaemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579\u2013H588","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-019-00586-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T00:21:10Z","timestamp":1585441270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-019-00586-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s10787-019-00586-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}